Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 262 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Switching to efavirenz versus remaining on ritonavir-boosted lopinavir in HIV-infected children exposed to nevirapine: long-term outcomes of a randomized trial.
    Clin Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. EATON EF, Gravett RM, Tamhane AR, Mugavero MJ, et al
    Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
    Clin Infect Dis. 2017 Apr 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. CHOW EPF, Callander D, Fairley CK, Zhang L, et al
    Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. GUARALDI G, Rockwood K
    Geriatric-HIV medicine is born.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    


  5. UNDERWOOD J, Cole JH, Caan M, De Francesco D, et al
    Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. WALENSKY RP, Del Rio C, Armstrong WS
    Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format    


  7. SINGH HK, Del Carmen T, Freeman R, Glesby MJ, et al
    From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. ADAORA A A, Cole SR, Eron JJ
    US Black Women and HIV Prevention: Time for New Approaches to Clinical Trials.
    Clin Infect Dis. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. QIN Q, Guo W, Tang W, Mahapatra T, et al
    Spatial Analysis of the Human Immunodeficiency Virus Epidemic among Men Who Have Sex with Men in China, 2006-2015.
    Clin Infect Dis. 2017;64:956-963.
    PubMed     Text format     Abstract available


  10. MORRIS MD, Shiboski S, Bruneau J, Hahn JA, et al
    Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
    Clin Infect Dis. 2017;64:860-869.
    PubMed     Text format     Abstract available


  11. SUNGKANUPARPH S, Savetamornkul C, Pattanapongpaiboon W
    Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/microL and Receiving Antiretroviral Therapy.
    Clin Infect Dis. 2017;64:967-970.
    PubMed     Text format     Abstract available


  12. BROGER T, Basu Roy R, Filomena A, Greef CH, et al
    Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.
    Clin Infect Dis. 2017;64:947-955.
    PubMed     Text format     Abstract available


  13. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  14. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. JOHS NA, Wu K, Tassiopoulos K, Koletar SL, et al
    Disability among Middle-Aged and Older Persons with HIV Infection.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. SOHN AH, Hazra R
    Old Problems for New Providers: Managing the Postpediatric HIV Generation.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format    


  17. JANSSEN S, Schutz C, Ward A, Nemes E, et al
    Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. BECOFSKY K, Wing EJ, McCaffery J, Bodreau M, et al
    A Randomized, Controlled Trial of a Behavioral Weight Loss Program for HIV-Infected Patients.
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. HWANG C, Schurmann D, Sobotha C, Boffito M, et al
    Antiviral Activity, Safety, and Exposure-Response relationships of GSK3532795, a Second-Generation HIV-1 Maturation Inhibitor, administered as Monotherapy or in Combination with Atazanavir+/-Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. ADACHI K, Xu J, Ank B, Watts DH, et al
    Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. MADHI SA, Nunes M, Weinberg A, Kuwanda L, et al
    Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. THOMAS M, Hopkins C, Duffy E, Lee D, et al
    Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. CURLIN ME, Gvetadze R, Leelawiwat W, Martin M, et al
    Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. GOURLAY A, Noori T, Pharris A, Axelsson M, et al
    The HIV continuum of care in European Union countries in 2013: data and challenges.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. BERSHETYN A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients.
    Clin Infect Dis. 2017 Mar 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. WHITE AC JR
    Treatment of Early Syphilis in HIV: What Do We Really Know?
    Clin Infect Dis. 2017;64:765-766.
    PubMed     Text format    


  28. COLLIER D, Iwuji C, Derache A, de Oliveira T, et al
    Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. HERRICK JA, Legrand F, Gounoue R, Nchinda G, et al
    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. KUGATHASAN R, Collier DA, Haddow LJ, El Bouzidi K, et al
    Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. CYKTOR JC, Mellors JW
    TLR Agonists: Can They Exact a Toll on HIV Persistence?
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format    


  34. VIBHOLM L, Schleimann MH, Hojen JF, Benfield T, et al
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. UPRETY P, Patel K, Karalius B, Ziemniak C, et al
    HIV-1 DNA Decay Dynamics with Early, Long-term Virologic Control of Perinatal Infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. PARKER RA, Rabideau DJ, Sax PE, Tierney C, et al
    The Impact of Medication Adherence on Virologic Failure in A5202, A Randomized, Partially-Blinded, Phase 3B Study.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. NEGOESCU DM, Zhang Z, Bucher HC, Bendavid E, et al
    Differentiated HIV Rna Viral Load Monitoring in Resource Limited Settings: An Economic Analysis.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  39. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. LAKE JE, Stanley T, Apovian C, Bhasin S, et al
    Practical Review of Recognition and Management of Obesity and Lipohypertrophy in HIV Infection.
    Clin Infect Dis. 2017 Feb 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. BORGES AH, Hoy J, Florence E, Sedlacek D, et al
    Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort.
    Clin Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. ELUL B, Saito S, Chung H, Hoos D, et al
    Attrition from HIV treatment programs in Africa: A longitudinal ecological analysis using data from 307,144 patients initiating antiretroviral therapy between 2005 and 2010.
    Clin Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. RAVIMOHAN S, Tamuhla N, Nfanyana K, Ni H, et al
    Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB.
    Clin Infect Dis. 2017 Feb 16. doi: 10.1093.
    PubMed     Text format    


  44. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2017;64:527-528.
    PubMed     Text format    


  45. MORRIS SR, Zhao M, Smith DM, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2017;64:428-434.
    PubMed     Text format    


  46. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.
    Clin Infect Dis. 2017;64:459-467.
    PubMed     Text format    


  47. LO RE V
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2017;64:498-500.
    PubMed     Text format    


  48. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017;64:490-497.
    PubMed     Text format    


  49. ANDRADE R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, et al
    Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  50. FONJUNGO PN, Alemnji GA, Kebede Y, Opio A, et al
    Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  51. CLIFFORD GM, Tully S, Franceschi S
    Carcinogenicity of human papillomavirus types in HIV-positive women: A meta-analysis from HPV infection to cervical cancer.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  52. YOUNG J, Rossi C, Gill J, Walmsley S, et al
    Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  53. BHATTACHARYA D, Belperio PS, Shahoumian TA, Loomis TP, et al
    Effectiveness of All-Oral Antiviral Regimens in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  54. BURTON MJ, Naggie S
    Real World Effectiveness of DAA Therapies in HIV/HCV Co-Infection: 996 Veterans Can't Be Wrong.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  55. BEGUELIN C, Friolet N, Moradpour D, Sahli R, et al
    Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  56. BAGHI HB, Aghazadeh M, Rashedi J, Poor BM, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


  57. ANDREONI M, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  58. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  59. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  60. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  61. FERRANDO-MARTINEZ S, De Pablo-Bernal RS, De Luna-Romero M, De Ory SJ, et al
    Thymic function failure is associated with HIV-disease progression.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  62. VINIKOOR MJ, Sinkala E, Chilengi R, Mulenga L, et al
    Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  63. DUGAST AS, Arnold K, Lofano G, Moore S, et al
    Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV.
    Clin Infect Dis. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


    January 2017
  64. PROANO A, Bravard MA, Lopez JW, Lee GO, et al
    Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. EL-MALLAWANY NK, Villiera J, Kamiyango W, Mhango J, et al
    Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi.
    Clin Infect Dis. 2017 Jan 11. pii: ciw879. doi: 10.1093.
    PubMed     Text format    


  66. RIVERO-JUAREZ A, Frias M, Lopez-Lopez P, Risalde ML, et al
    Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection?
    Clin Infect Dis. 2017 Jan 11. pii: cix004. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. BANNAZADEH BAGHI H, Aghazadeh M, Rashedi J, Mahdavi Poor B, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Jan 11. pii: cix006. doi: 10.1093.
    PubMed     Text format    


    December 2016
  68. SORIA A, Alteri C, Scarlatti G, Bertoli A, et al
    Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report.
    Clin Infect Dis. 2016 Dec 28. pii: ciw851. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. PINTYE J, Drake AL, Kinuthia J, Unger JA, et al
    A risk assessment tool for identifying pregnant and postpartum women who may benefit from pre-exposure prophylaxis (PrEP).
    Clin Infect Dis. 2016 Dec 28. pii: ciw850. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. LIN A, Ong KJ, Hobbelen P, King E, et al
    Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men.
    Clin Infect Dis. 2016 Dec 23. pii: ciw845. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. PATEL EU, Kirkpatrick AR, Grabowski MK, Kigozi G, et al
    Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Clin Infect Dis. 2016 Dec 22. pii: ciw847. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. MASSIMO A, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2016 Dec 22. pii: ciw846. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  74. CRANSTON RD, Lama JR, Richardson BA, Carballo-Dieguez A, et al
    MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  75. LO RE V 3RD
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  76. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  77. MATTSON CL, Bradley H, Beer L, Johnson C, et al
    Increased STD testing among sexually active persons receiving medical care for HIV infection in the United States, 2009 - 2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  78. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  79. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  80. SHIELS MS, Althoff KN, Pfeiffer RM, Achenbach CJ, et al
    HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  81. MAZUR NI, Bont L, Cohen AL, Cohen C, et al
    Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection with Viral Coinfection in HIV-uninfected Children.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  82. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  83. MORRIS SR, Zhao M, Smith DR, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  84. WALL EC, Mukaka M, Scarborough M, Ajdukiewicz KM, et al
    Prediction of outcome from adult bacterial meningitis in a high HIV seroprevalence, resource-poor setting using the Malawi Adult Meningitis Score (MAMS).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  85. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  86. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  87. MYER L, Dunning L, Lesosky M, Hsiao NY, et al
    Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy during pregnancy: a cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  88. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother to Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  89. BARGER-KAMATE B, Deloria Knoll M, Kagucia EW, Prosperi C, et al
    Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  90. NUNES MC, Downs S, Jones S, van Niekerk N, et al
    Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  91. SOOFIE N, Nunes MC, Kgagudi P, van Niekerk N, et al
    The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  92. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    November 2016
  93. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
    Clin Infect Dis. 2016 Nov 15. pii: ciw765. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. MEIJIDE H, Mena A, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Cancer Incidence in Persons Living With HIV.
    Clin Infect Dis. 2016 Nov 14. pii: ciw759. doi: 10.1093.
    PubMed     Text format    


  95. BADER J, Daumer M, Schoni-Affolter F, Boni J, et al
    Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  96. PANACKAL AA, Komori M, Kosa P, Khan O, et al
    Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
    Clin Infect Dis. 2016 Nov 10. pii: ciw739. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. GAISA M, Ita-Nagy F, Sigel K, Arens Y, et al
    High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  98. FOSTER AL, Gaisa MM, Hijdra RM, Turner SS, et al
    Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2016 Nov 9. pii: ciw740. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  99. BHARTI AR, McCutchan A, Deutsch R, Smith DM, et al
    Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  100. PELOQUIN CA, Dorman SE, Vernon A, Battista Migliori G, et al
    Reply to Alffenaar et al.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  101. HUNT PW
    Very Early ART and Persistent Inflammation in Treated HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  102. ROSADO-SANCHEZ I, Herrero-Fernandez I, Genebat M, Ruiz-Mateos E, et al
    Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  103. WU H, Mendoza MC, Huang YA, Hayes T, et al
    Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  104. RUSSELL K, Hills SL, Oster AM, Porse CC, et al
    Male-to-Female Sexual Transmission of Zika Virus-United States, January-April 2016.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  105. SAINZ T, Navarro ML
    HIV-Infected Youths: Transition in Spain Compared to the Netherlands.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  106. GOLDSCHMIDT RH
    Preexposure Prophylaxis in the United States: An Evolving HIV Prevention Opportunity.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  107. DELANEY KP, Hanson DL, Masciotra S, Ethridge SF, et al
    Time until emergence of HIV test reactivity following infection with HIV-1: Implications for interpreting test results and retesting after exposure.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  108. SERETI I, Krebs SJ, Phanuphak N, Fletcher JL, et al
    Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  109. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    PubMed     Text format    


  110. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016;63:853-67.
    PubMed     Text format     Abstract available


    September 2016
  111. COHEN M, Eshleman S, McCauley M, Chen Y, et al
    Antiretroviral therapy to prevent HIV acquisition: Limits of estimation from a population cohort.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  112. SELHORST P, Masson L, Ismail SD, Samsunder N, et al
    CErvicovaginal inflaMmation Facilitates Acquisition of less infectious HIV variants.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  113. LJUNGMAN P, Boeckh M, Hirsch HH, Josephson F, et al
    Definitions of CMV infection and disease in transplant patients for use in clinical trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  114. NAGGIE S, Holland D, Sulkowski MS, Thomas DL, et al
    HCV post-exposure prophylaxis in the healthcare worker: Why DAAs don't change a thing.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  115. BORDONI V, Sacchi A, Cimini E, Casetti R, et al
    Different Role of IL-7 and IL-18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected patients.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  116. BROCK JB, Mena LA
    HIV Medicine Residency Training Correspondence.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  117. BOERMA RS, Boender TS, Bussink AP, Calis JC, et al
    Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  118. CASTILLO-MANCILLA JR, Brown TT, Erlandson KM, Palella FJ Jr, et al
    Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  119. THOMPSON-PAUL AM, Lichtenstein KA, Armon C, Palella FJ Jr, et al
    Cardiovascular disease risk prediction in the HIV Outpatient Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  120. BORGES AH, Neuhaus J, Babiker AG, Henry K, et al
    Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  121. SMITH DM, Nakazawa M, Freeman ML, Anderson CM, et al
    Asymptomatic CMV Replication during Early HIV-infection is Associated with Lower CD4/CD8 Ratio during HIV Treatment.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  122. JUDD A, Le Prevost M, Melvin D, Arenas-Pinto A, et al
    Cognitive function in young people with and without perinatal HIV in the AALPHI cohort in England: the role of non-HIV related factors.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  123. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  124. TINCATI C, Rainone V, Comi L, Pandolfo A, et al
    Cell-Mediated Immunity in HIV-Infected Males with HPV-Related Anal Dysplastic Lesions.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  125. JOHNSON G, Levison J, Malek J
    Should providers discuss breastfeeding with women living with HIV in high-income countries? An ethical analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  126. TAO G, Hoover KW, Nye MB, Peters P, et al
    Rectal infection with Neisseria gonorrhoeae and Chlamydia trachomatis in males in the United States.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  127. DRABO EF, Hay JW, Vardavas R, Wagner ZR, et al
    A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  128. MAYER KH, Krakower DS
    Can We Afford to Control the HIV Epidemic with Antiretrovirals? Can We Afford Not to Do So?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  129. GREBELY J, Mauss S, Brown A, Bronowicki JP, et al
    Efficacy and safety of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic HCV genotype 1 infection receiving opioid substitution therapy: Analysis of Phase 3 ION trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  130. POTARD V, Simon A, Lacombe JM, Parienti JJ, et al
    Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  131. SALINAS JL, Rentsch C, Marconi VC, Tate J, et al
    Baseline, Time-updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  132. Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  133. INGILIZ P, Christensen S, Kimhofer T, Hueppe D, et al
    Sofosbuvir and Ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus infection in HCV-mono-infected and HIV-HCV co-infected individuals - Results from the German hepatitis C cohort (GECCO-01).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  134. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  135. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  136. KLEIN MB, Althoff KN, Jing Y, Lau B, et al
    Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  137. ABRAVANEL F, Metivier S, Chauveau M, Peron JM, et al
    Transmission of HCV NS5A inhibitor-resistant variants among HIV-infected men who have sex with men.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  138. KAMSTRA R, Azoulay L, Steele R, Klein MB, et al
    Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  139. BOETTIGER DC, Muktiarti D, Kurniati N, Truong KH, et al
    Early height and weight changes in children using cotrimoxazole prophylaxis with antiretroviral therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  140. HAAS AD, Msukwa MT, Egger M, Tenthani L, et al
    Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's "Option B+" programme.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  141. MUKERJI SS, Locascio JJ, Misra V, Lorenz DR, et al
    Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  142. HANNA DB, Ramaswamy C, Kaplan RC, Kizer JR, et al
    Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  143. WEIJSENFELD AM, Smit C, Cohen S, Wit FW, et al
    Virological and Social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  144. BARLOW-MOSHA L, Angelidou K, Lindsey J, Archary M, et al
    Nevirapine- vs Lopinavir/Ritonavir-based Antiretroviral Therapy in HIV-infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available



  145. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  146. WYLES DL, Sulkowski MS, Dieterich D
    Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Clin Infect Dis. 2016;63 Suppl 1:S3-S11.
    PubMed     Text format     Abstract available


  147. MACBRAYNE CE, Kiser JJ
    Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016;63 Suppl 1:S12-23.
    PubMed     Text format     Abstract available


  148. WANGPATHARAWANIT P, Sungkanuparph S
    Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  149. ROWAN SE, Rogers M, Bayer J, Smith L, et al
    Treatment of HCV in HIV coinfected individuals in real world clinical settings: results from two large HIV care clinics.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  150. AL-KINDI SG, Zidar DA, McComsey GA, Longenecker CT, et al
    Gender differences in statin prescription rate among patients living with HIV and HCV.
    Clin Infect Dis. 2016.
    PubMed     Text format    


    June 2016
  151. CREPAZ N, Tang T, Marks G, Mugavero MJ, et al
    Durable Viral Suppression and Transmission Risk Potential among Persons with Diagnosed HIV Infection: United States, 2012-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  152. WEISER J, Beer L, West BT, Duke CC, et al
    Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  153. LYKINS J, Wang K, Wheeler K, Clouser F, et al
    Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  154. WADA NI, Bream JH, Martinez-Maza O, Macatangay B, et al
    Inflammatory biomarkers predict mortality among HIV-suppressed men: a multisite prospective cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  155. LOW AJ, Mburu G, Welton NJ, May MT, et al
    Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: a Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  156. BLOCH M, Kamminga J, Jayewardene A, Bailey M, et al
    A Screening Strategy for HIV-Associated Neurocognitive Disorders (HAND) that Accurately Identifies Patients Requiring Neurological Review.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  157. KEATING SM, Pilcher CD, Busch MP
    Timing is Everything - Shortcomings of Current HIV Diagnostics in the Early Treatment Era.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  158. DE SOUZA MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, et al
    Initiation of Antiretroviral Therapy during Acute HIV-1 Infection leads to A High Rate of Non-Reactive HIV Serology.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  159. SOGNI P, Gilbert C, Lacombe K, Piroth L, et al
    All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 - HEPAVIH cohort.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  160. ISA SE, Oche AO, Kang'ombe AR, Okopi JA, et al
    HIV and risk of type 2 diabetes in a large adult cohort in Jos, Nigeria.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  161. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  162. GJAERDE LI, Shepherd L, Jablonowska E, Lazzarin A, et al
    Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  163. SCOTT C, Cavanaugh JS, Pratt R, Silk BJ, et al
    Human tuberculosis caused by Mycobacterium bovis in the United States, 2006-2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  164. HOOTS BE, Finlayson T, Nerlander L, Paz-Bailey G, et al
    Willingness to Take, Use of, and Indications for Pre-Exposure Prophylaxis among Men Who Have Sex with Men - 20 U.S. Cities, 2014.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  165. HEIDARY M, Nasiri MJ, Goudarzi M
    Why the HIV/AIDS prevalence was increased in Iran, despite the decreasing in the USA?
    Clin Infect Dis. 2016.
    PubMed     Text format    


    May 2016
  166. COOPER C, Naggie S, Saag M, Yang JC, et al
    Successful Retreatment of HCV in Patients Coinfected with HIV Who Failed 12 Weeks of Ledipasvir/Sofosbuvir.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  167. KELLY EM, Dodge JL, Sarkar M, French AL, et al
    Marijuana Use is not Associated with Progression to Advanced Liver Fibrosis in HIV/HCV Coinfected Women.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  168. GIORDANO TP, Cully J, Amico KR, Davila JA, et al
    A randomized trial to test a peer mentor intervention to improve outcomes in persons hospitalized with HIV infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  169. OLDENBURG CE, Barnighausen T, Tanser F, Iwuji CC, et al
    Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  170. MARQUINE MJ, Montoya JL, Umlauf A, Fazeli PL, et al
    The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  171. OFOTOKUN I, Titanji K, Lahiri CD, Vunnava A, et al
    A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naive HIV-infected Patients: a Phase IIb Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  172. GLAUBIUS RL, Hood G, Penrose KJ, Parikh UM, et al
    Cost-Effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  173. TUDOR C, Van der Walt ML, Margot B, Dorman SE, et al
    Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2016;62 Suppl 3:S255-61.
    PubMed     Text format     Abstract available


  174. WOUTERS E, Rau A, Engelbrecht M, Uebel K, et al
    The Development and Piloting of Parallel Scales Measuring External and Internal HIV and Tuberculosis Stigma Among Healthcare Workers in the Free State Province, South Africa.
    Clin Infect Dis. 2016;62 Suppl 3:S244-54.
    PubMed     Text format     Abstract available


  175. VERKUIJL S, Middelkoop K
    Protecting Our Front-liners: Occupational Tuberculosis Prevention Through Infection Control Strategies.
    Clin Infect Dis. 2016;62 Suppl 3:S231-7.
    PubMed     Text format     Abstract available


  176. EVANS TG, Bekker LG
    Tuberculosis and Healthcare Workers in Underresourced Settings.
    Clin Infect Dis. 2016;62 Suppl 3:S229-30.
    PubMed     Text format    


  177. MEHTA SR, Murrell B, Anderson CM, Kosakovsky Pond SL, et al
    Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  178. REIDY W, Agarwal M, Chege D, Lamb M, et al
    Retention in Care Among HIV-Infected Patients on Antiretroviral Therapy and Among Those Not on Antiretroviral Therapy in Eastern Africa.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  179. TUCKER JD, Cao B, Li H, Tang S, et al
    Social Media Interventions to Promote HIV Testing.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  180. HOENIGL M, Chaillon A, Little SJ
    CD4/CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  181. VAN ZOEST RA, Wit FW, Kooij KW, van der Valk M, et al
    Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  182. PARIKH S, Kajubi R, Huang L, Ssebuliba J, et al
    Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  183. SOLLIMA S, D'Avolio A, Cattaneo D, Micheli V, et al
    Darunavir-based antiretroviral therapy may affect the efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir in HCV/HIV-1 coinfected patients.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  184. FEHINTOLA FA, Adedeji WA, Morse GD
    Malaria and HIV/AIDS interaction in Ugandan children.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  185. CLEMENT ME, Park LP, Navar AM, Okeke NL, et al
    Statin Utilization and Recommendations Among HIV and HCV-Infected Veterans: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  186. ARENAS-PINTO A, Stohr W, Jager R, Haddow L, et al
    Neurocognitive function and neuroimaging markers in virologically suppressed HIV-positive patients randomised to ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  187. MCMANUS KA, Rhodes A, Bailey S, Yerkes L, et al
    Affordable Care Act Qualified Health Plan Coverage is Associated with Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Non-expansion State.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  188. BERRY SA, Fleishman JA, Yehia BR, Cheever LW, et al
    Healthcare Coverage for HIV Provider Visits before and after Implementation of the Affordable Care Act.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  189. BAR-ZEEV N, Jere KC, Bennett A, Pollock L, et al
    Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
    Clin Infect Dis. 2016;62 Suppl 2:S213-9.
    PubMed     Text format     Abstract available


  190. GROOME MJ, Zell ER, Solomon F, Nzenze S, et al
    Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.
    Clin Infect Dis. 2016;62 Suppl 2:S188-95.
    PubMed     Text format     Abstract available


    April 2016
  191. SHEN Y, Yu VL, Lu H
    Control of HIV for Men Who Have Sex With Men in China: A Role for the Internet?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  192. MI G, Ma B, Kleinman N, Li Z, et al
    Hidden and Mobile: A Web-based Study of Migration Patterns of Men Who Have Sex With Men in China.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  193. TANG W, Han L, Best J, Zhang Y, et al
    Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  194. NICOLAS D, Esteve A, Cuadros A, Campbell CN, et al
    Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  195. HANNA DB, Guo M, Buzkova P, Miller TL, et al
    HIV infection and carotid artery intima-media thickness: Pooled analyses across five cohorts of the NHLBI HIV-CVD Collaborative.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  196. VAN DUIN D, Bonomo RA
    Ceftazidime/Avibactam and Ceftolozane/Tazobactam: "Second generation" beta-Lactam/beta-Lactamase Combinations.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  197. OKEKE NL, Davy T, Eron JJ, Napravnik S, et al
    Hypertension among HIV-infected Patients in Clinical Care, 1996 - 2013.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  198. BORGES AH, Lundh A, Tendal B, Bartlett JA, et al
    Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based regimens for initial treatment of HIV infection: a systematic review and meta-analysis of randomised trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  199. VAN DYKE RB, Patel K, Kagan RM, Karalius B, et al
    Antiretroviral Drug Resistance Among Children and Youth in the U.S. with Perinatal HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  200. PETT SL, Amin J, Horban A, Andrade-Villanueva J, et al
    Maraviroc, as a switch option, in HIV-1 infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first N(t)RTI+PI/r regimen. Week 48 results of the randomised, multicentre MARaviroc switCH study (MARCH).
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  201. BARNETT PG, Schmitt SK, Yu W, Goetz MB, et al
    How will new guidelines affect CD4 testing in Veterans with HIV?
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  202. JONES-LOPEZ EC, Acuna-Villaorduna C, Ssebidandi M, Gaeddert M, et al
    Cough Aerosols of Mycobacterium tuberculosis Predict Incident Tuberculosis Disease in Household Contacts.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  203. LUETKEMEYER AF, McDonald C, Ramgopal M, Noviello S, et al
    12 Weeks of Daclatasvir in Combination with Sofosbuvir for HIV-HCV Coinfection (ALLY-2 study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  204. ZHANG N, Bussell S, Wang G, Zhu X, et al
    Disparities in HIV Care Along the Path From Infection to Viral Suppression: a Cross-Sectional Study of HIV/AIDS Patient Records in 2013, Shandong Province, China.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  205. MAY MT, Vehreschild JJ, Trickey A, Obel N, et al
    Mortality according to CD4 count at start of combination antiretroviral therapy among HIV positive patients followed for up to 15 years after start of treatment: collaborative cohort study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  206. JAO J, Abrams EJ, Phillips T, Petro G, et al
    In Utero Tenofovir Exposure Is Not Associated with Fetal Long Bone Growth.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  207. MERRY M, Boulware DR
    Cryptococcal Meningitis Treatment Strategies: A Cost-Effectiveness Analysis in the United States affected by the Explosive Cost of Flucytosine.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  208. FREEMAN ML, Mudd JC, Shive CL, Younes SA, et al
    Reply to Barrett, et al.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  209. SHEN Z, Zhu Q, Tang Z, Pan SW, et al
    Effects of CD4 and viral load testing on mortality among HIV patients receiving antiretroviral treatment: an observational cohort study in rural southwest China.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  210. BARRETT L, Fudge NJ, Heath JJ, Grant MD, et al
    Cytomegalovirus Immunity and Exhaustive CD8+ T cell Proliferation in Treated Human Immunodeficiency Virus Infection.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  211. B-LAJOIE MR, Drouin O, Bartlett G, Nguyen Q, et al
    Incidence and prevalence of opportunistic and other infections and the impact of antiretroviral therapy among HIV-infected children in low and middle-income countries: a systematic review and meta-analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  212. RHODES SD, McCoy TP, Tanner AE, Stowers J, et al
    Using social media to increase HIV testing among gay and bisexual men, other MSM, and transgender persons: Outcomes from a randomized community trial.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  213. BARBEE LA, Golden MR
    When to perform a test of cure for gonorrhea: controversies and evolving data.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  214. NYITRAY AG, Carvalho da Silva RJ, Chang M, Baggio ML, et al
    Incidence, duration, persistence, and factors associated with high-risk anal HPV persistence among HIV-negative men having sex with men: A multi-national study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  215. RICHMAN DD
    HIV is putting up less resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  216. SCHERRER AU, von Wyl V, Yang WL, Kouyos R, et al
    Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  217. LOW A, Gavriilidis G, Larke N, Lajoie MR, et al
    Incidence of Opportunistic Infections and the impact of Antiretroviral Therapy among HIV-Infected Adults in Low and Middle Income Countries: a Systematic Review and Meta-analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  218. SIBERRY GK, Jacobson DL
    Reply to Author: Koo et al.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  219. DOMINGUEZ-MOLINA B, Leon A, Rodriguez C, Benito JM, et al
    Analysis of Non-AIDS-defining Events in HIV controllers.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  220. OUATTARA EN, Robine M, Eholie SP, MacLean RL, et al
    Laboratory monitoring of antiretroviral therapy for HIV infection: Cost-effectiveness and budget impact of current and novel strategies.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  221. DEL BELLO D, Cha A, Sorbera M, Bichoupan K, et al
    Real-world Sustained Virologic Response Rates of Sofosbuvir-containing Regimens in Patients Coinfected with Hepatitis C and HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  222. ZAKHOUR R, Tran DQ, Degaffe G, Bell CS, et al
    Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  223. HSIEH YH, Rothman RE, Laeyendecker OB, Kelen GD, et al
    Evaluation of The CDC Recommendations for HCV Testing in an Urban Emergency Department.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  224. MARTIN NK, Thornton A, Hickman M, Sabin C, et al
    Can HCV direct-acting antiviral treatment as prevention reverse the HCV epidemic amongst men who have sex with men in the UK - epidemiological and modelling insights.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  225. TIBERI S, Sotgiu G, D'Ambrosio L, Centis R, et al
    Comparison of effectiveness and safety of imipenem/clavulanate added to an optimised background regimen (OBR) versus OBR controls regimens in the treatment of multidrug and extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  226. CABY F, Guihot A, Lambert-Niclot S, Guiguet M, et al
    Determinants of a low CD4/CD8 ratio in HIV-1-infected individuals despite long-term viral suppression.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  227. MARCY O, Ung V, Goyet S, Borand L, et al
    Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  228. THIEBAUT R, Jarne A, Routy JP, Sereti I, et al
    Repeated Cycles of Recombinant Human Interleukin-7 in HIV-Infected Patients with low CD4 T cell Reconstitution on Antiretroviral Therapy: Results of two Phase II Multicentre Studies.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  229. FIRNHABER C, Kendall MA, Wu X, Mazurek GH, et al
    Evaluation of Xpert MTB/RIF to identify pulmonary tuberculosis in tuberculosis suspects from low and higher prevalence settings compared to acid fast smear and culture.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  230. YING R, Granich RM, Gupta S, Williams BG, et al
    CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.
    Clin Infect Dis. 2016 Jan 29. pii: civ1224.
    PubMed     Text format     Abstract available


  231. MCCOMSEY GA, Moser C, Currier J, Ribaudo HJ, et al
    Body Composition Changes after Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  232. CALDERON MM, Penzak SR, Pau AK, Kumar P, et al
    Efavirenz (EFV) but not Atazanavir/ritonavir (ATV/r) Significantly Reduces Atovaquone Concentrations in HIV-infected Subjects.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  233. GLIDDEN DV, Amico KR, Liu AY, Hosek SG, et al
    Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  234. SIMMONS B, Saleem J, Hill A, Riley RD, et al
    Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  235. ROBERTS T, Cohn J, Bonner K, Hargreaves S, et al
    Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  236. SAEED S, Strumpf EC, Walmsley S, Rollet-Kurhajec K, et al
    How generalizable are the results from trials of Direct Antiviral Agents to people coinfected with HIV/Hepatitis C virus in the real world?
    Clin Infect Dis. 2016 Jan 6. pii: civ1222.
    PubMed     Text format     Abstract available


  237. CERVIA JS
    Addressing the Needs of Youth with HIV Infection in the Era of Combination Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  238. MENARD A, Colson P, Catherine D, Isabelle R, et al
    First real life evidence of new direct-acting antivirals (DAA) in co-infected HIV HCV patients: better than ever.
    Clin Infect Dis. 2016 Jan 5. pii: civ1215.
    PubMed     Text format    


  239. KHATRI A, Dutta S, Wang H, Podsadecki T, et al
    Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.
    Clin Infect Dis. 2016 Jan 5. pii: civ1213.
    PubMed     Text format     Abstract available


    December 2015
  240. GARNER W, White K, Szwarcberg J, McCallister S, et al
    Concordance of HIV-1 RNA Values by Amplicor and TaqMan2.0 in Patients with Confirmed Suppression in Clinical Trials.
    Clin Infect Dis. 2015 Dec 21. pii: civ1034.
    PubMed     Text format     Abstract available


  241. GENG EH, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care among HIV-infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach.
    Clin Infect Dis. 2015 Dec 17. pii: civ1004.
    PubMed     Text format     Abstract available


  242. SENA AC, Hsu KK, Kellogg N, Girardet R, et al
    Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children.
    Clin Infect Dis. 2015;61 Suppl 8:S856-64.
    PubMed     Text format     Abstract available


  243. PARK IU, Introcaso C, Dunne EF
    Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Clin Infect Dis. 2015;61 Suppl 8:S849-55.
    PubMed     Text format     Abstract available


  244. MEITES E, Gaydos CA, Hobbs MM, Kissinger P, et al
    A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Clin Infect Dis. 2015;61 Suppl 8:S837-48.
    PubMed     Text format     Abstract available


  245. GHANEM KG
    Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Clin Infect Dis. 2015;61 Suppl 8:S818-36.
    PubMed     Text format     Abstract available


  246. WORKOWSKI KA
    Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Clin Infect Dis. 2015;61 Suppl 8:S759-62.
    PubMed     Text format    


  247. POLIZZOTTO MN, Uldrick TS, Wyvill KM, Aleman K, et al
    Clinical features and outcomes of patients with symptomatic KSHV-associated inflammation: prospective characterization of the Kaposi sarcoma herpesvirus inflammatory cytokine syndrome (KICS).
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  248. WALENSKY RP, Horn TH, Paltiel AD
    The epi-TAF for TDF?
    Clin Infect Dis. 2015 Dec 9. pii: civ1000.
    PubMed     Text format     Abstract available


  249. GUPTA A, Mathad JS, Abdel-Rahman SM, Albano JD, et al
    Towards Earlier Inclusion of Pregnant and Postpartum Women in TB Drug Trials: Consensus Statements from an International Expert Panel.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  250. KOENIG SP, Pape JW
    Stemming the Tide: Can New Approaches to HIV Treatment Reverse the Trend of Rising Drug Prices in the United States?
    Clin Infect Dis. 2015.
    PubMed     Text format    


  251. GIROUARD MP, Sax PE, Parker RA, Taiwo B, et al
    The cost-effectiveness and budget impact of two-drug dolutegravir-lamivudine regimens for the treatment of HIV infection in the United States.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  252. SCARSI KK, Darin KM, Nakalema S, Back DJ, et al
    Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks.
    Clin Infect Dis. 2015 Dec 8. pii: civ1001.
    PubMed     Text format     Abstract available


  253. LE JONCOUR A, Bidegain F, Ziol M, Galicier L, et al
    Hemophagocytic lymphohistiocytosis associated with Bartonella henselae infection in a HIV- infected patient.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  254. HOFSTRA LM, Sauvageot N, Albert J, Alexiev I, et al
    Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  255. RAVIMOHAN S, Tamuhla N, Nfanyana K, Steenhoff AP, et al
    Robust reconstitution of TB-specific polyfunctional CD4+ T-cell responses and rising systemic IL-6 in paradoxical TB-IRIS.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  256. FORD N, Shubber Z
    Reply to Zimmer.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  257. ZIMMER R
    HIV PEP starter packs were not designed to help or hinder adherence.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  258. MAGARET AS, Mujugira A, Hughes JP, Lingappa J, et al
    Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  259. COLASANTI J, Kelly J, Pennisi E, Hu YJ, et al
    Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  260. LONGLEY N, Jarvis JN, Meintjes G, Boulle A, et al
    Cryptococcal Antigen Screening in Patients Initiating ART In South Africa: A Prospective Cohort Study.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  261. SCARSI KK, Eisen G, Darin KM, Meloni ST, et al
    Superior effectiveness of zidovudine compared to tenofovir when combined with nevirapine-based antiretroviral therapy in a large Nigerian Cohort.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  262. MILLOY MJ, Wood E, Kerr T, Hogg B, et al
    Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide Treatment-as-Prevention initiative.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: